Article ID Journal Published Year Pages File Type
2966804 Journal of Clinical Lipidology 2009 12 Pages PDF
Abstract
Slo-Niacin® 1.5 g/d with atorvastatin 10 mg/d improved lipoprotein lipids, apoproteins, and inflammation markers without hepatotoxicity. Slo-Niacin® deserves further study as a cost-effective treatment of hyperlipidemia. (ClinicalTrials.gov Identifier: NCT00194402)
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , , , , , , , ,